Valdivielso-Ramos M, Hernanz J M
Departamento de Dermatología, Hospital Infanta Leonor, Madrid, España.
Actas Dermosifiliogr. 2012 Dec;103(10):863-873. doi: 10.1016/j.ad.2011.12.005. Epub 2012 Apr 4.
Dermatofibrosarcoma protuberans (DFSP) is a fibrohistiocytic tumor of intermediate malignancy that is very rare in childhood. Only 6% of these tumors present in children. Clinical diagnosis is very difficult in the early stages of disease, but to ensure appropriate treatment it is important to identify DFSP as early as possible and rule out benign conditions that are more common at this age. The clinical presentation and histopathologic and molecular characteristics of DFSP are similar in children and adults. Clinical diagnosis is, however, more difficult in children and requires a high degree of suspicion. The absence of characteristic features and the rarity of this tumor explain why diagnosis is often delayed. Complete surgical excision of the tumor is very important to reduce the risk of recurrence. This article presents a review of current knowledge about the management of DFSP in children and examines the latest treatment options.
隆突性皮肤纤维肉瘤(DFSP)是一种中度恶性的纤维组织细胞肿瘤,在儿童中非常罕见。这些肿瘤仅6%发生于儿童。在疾病早期临床诊断非常困难,但为确保适当治疗,尽早识别DFSP并排除该年龄段更常见的良性疾病很重要。DFSP在儿童和成人中的临床表现、组织病理学及分子特征相似。然而,儿童的临床诊断更困难,需要高度怀疑。缺乏特征性表现以及该肿瘤的罕见性解释了为何诊断常常延迟。肿瘤的完整手术切除对于降低复发风险非常重要。本文综述了目前关于儿童DFSP治疗的知识,并探讨了最新的治疗选择。